Eosinophil aktivációs markerek status asthmaticusban.

Translated title of the contribution: Eosinophil activation markers in status asthmaticus

L. Nagy, Z. Süttö, E. Tolnay, K. Terék, M. Orosz, O. Szentpály

Research output: Contribution to journalArticle

Abstract

Eosinophil activation markers-eosinophil cationic protein, eosinophil protein-X-were investigated in acute severe asthma. The elevation of the eosinophil activity markers were found in every cases at the time of admission. The measurements were repeated eight days later. The eosinophil cationic protein and eosinophil protein-X levels were increased at the time of the admission, and a decreasing tendency was detected eight days later. The peak expiratory flow rates were monitored during the period of the hospital staying. It is important to note that, the size of the bronchial obstruction did not show any similarity in all cases comparing to the elevation or decrease of eosinophil activity markers. The authors proved the eosinophil activation in vivo in acute severe asthma. The continuous monitor of the eosinophil activity markers might have a practical value in searching of the optimal therapeutic modalities in the asthmatic patients.

Original languageHungarian
Pages (from-to)121-124
Number of pages4
JournalOrvosi Hetilap
Volume137
Issue number3
Publication statusPublished - Jan 21 1996

Fingerprint

Status Asthmaticus
Eosinophils
Eosinophil-Derived Neurotoxin
Eosinophil Cationic Protein
Asthma
Peak Expiratory Flow Rate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nagy, L., Süttö, Z., Tolnay, E., Terék, K., Orosz, M., & Szentpály, O. (1996). Eosinophil aktivációs markerek status asthmaticusban. Orvosi Hetilap, 137(3), 121-124.

Eosinophil aktivációs markerek status asthmaticusban. / Nagy, L.; Süttö, Z.; Tolnay, E.; Terék, K.; Orosz, M.; Szentpály, O.

In: Orvosi Hetilap, Vol. 137, No. 3, 21.01.1996, p. 121-124.

Research output: Contribution to journalArticle

Nagy, L, Süttö, Z, Tolnay, E, Terék, K, Orosz, M & Szentpály, O 1996, 'Eosinophil aktivációs markerek status asthmaticusban.', Orvosi Hetilap, vol. 137, no. 3, pp. 121-124.
Nagy L, Süttö Z, Tolnay E, Terék K, Orosz M, Szentpály O. Eosinophil aktivációs markerek status asthmaticusban. Orvosi Hetilap. 1996 Jan 21;137(3):121-124.
Nagy, L. ; Süttö, Z. ; Tolnay, E. ; Terék, K. ; Orosz, M. ; Szentpály, O. / Eosinophil aktivációs markerek status asthmaticusban. In: Orvosi Hetilap. 1996 ; Vol. 137, No. 3. pp. 121-124.
@article{5f6aad84429e44d09feb64451f43d8fd,
title = "Eosinophil aktiv{\'a}ci{\'o}s markerek status asthmaticusban.",
abstract = "Eosinophil activation markers-eosinophil cationic protein, eosinophil protein-X-were investigated in acute severe asthma. The elevation of the eosinophil activity markers were found in every cases at the time of admission. The measurements were repeated eight days later. The eosinophil cationic protein and eosinophil protein-X levels were increased at the time of the admission, and a decreasing tendency was detected eight days later. The peak expiratory flow rates were monitored during the period of the hospital staying. It is important to note that, the size of the bronchial obstruction did not show any similarity in all cases comparing to the elevation or decrease of eosinophil activity markers. The authors proved the eosinophil activation in vivo in acute severe asthma. The continuous monitor of the eosinophil activity markers might have a practical value in searching of the optimal therapeutic modalities in the asthmatic patients.",
author = "L. Nagy and Z. S{\"u}tt{\"o} and E. Tolnay and K. Ter{\'e}k and M. Orosz and O. Szentp{\'a}ly",
year = "1996",
month = "1",
day = "21",
language = "Hungarian",
volume = "137",
pages = "121--124",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Eosinophil aktivációs markerek status asthmaticusban.

AU - Nagy, L.

AU - Süttö, Z.

AU - Tolnay, E.

AU - Terék, K.

AU - Orosz, M.

AU - Szentpály, O.

PY - 1996/1/21

Y1 - 1996/1/21

N2 - Eosinophil activation markers-eosinophil cationic protein, eosinophil protein-X-were investigated in acute severe asthma. The elevation of the eosinophil activity markers were found in every cases at the time of admission. The measurements were repeated eight days later. The eosinophil cationic protein and eosinophil protein-X levels were increased at the time of the admission, and a decreasing tendency was detected eight days later. The peak expiratory flow rates were monitored during the period of the hospital staying. It is important to note that, the size of the bronchial obstruction did not show any similarity in all cases comparing to the elevation or decrease of eosinophil activity markers. The authors proved the eosinophil activation in vivo in acute severe asthma. The continuous monitor of the eosinophil activity markers might have a practical value in searching of the optimal therapeutic modalities in the asthmatic patients.

AB - Eosinophil activation markers-eosinophil cationic protein, eosinophil protein-X-were investigated in acute severe asthma. The elevation of the eosinophil activity markers were found in every cases at the time of admission. The measurements were repeated eight days later. The eosinophil cationic protein and eosinophil protein-X levels were increased at the time of the admission, and a decreasing tendency was detected eight days later. The peak expiratory flow rates were monitored during the period of the hospital staying. It is important to note that, the size of the bronchial obstruction did not show any similarity in all cases comparing to the elevation or decrease of eosinophil activity markers. The authors proved the eosinophil activation in vivo in acute severe asthma. The continuous monitor of the eosinophil activity markers might have a practical value in searching of the optimal therapeutic modalities in the asthmatic patients.

UR - http://www.scopus.com/inward/record.url?scp=17944390344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944390344&partnerID=8YFLogxK

M3 - Article

C2 - 8721862

AN - SCOPUS:17944390344

VL - 137

SP - 121

EP - 124

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 3

ER -